1. Home
  2. BTG vs LEGN Comparison

BTG vs LEGN Comparison

Compare BTG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B2Gold Corp

BTG

B2Gold Corp

HOLD

Current Price

$5.87

Market Cap

7.3B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$21.25

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTG
LEGN
Founded
2006
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.9B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
BTG
LEGN
Price
$5.87
$21.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$6.00
$61.33
AVG Volume (30 Days)
24.0M
2.6M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$38.08
$42.68
Revenue Next Year
$28.46
$30.52
P/E Ratio
$34.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.57
$16.24
52 Week High
$6.29
$37.50

Technical Indicators

Market Signals
Indicator
BTG
LEGN
Relative Strength Index (RSI) 74.43 47.78
Support Level $4.82 $20.70
Resistance Level $5.77 $21.97
Average True Range (ATR) 0.20 1.08
MACD 0.08 0.40
Stochastic Oscillator 95.09 56.09

Price Performance

Historical Comparison
BTG
LEGN

About BTG B2Gold Corp

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: